Cargando…

Projected Prevalence of Actionable Pharmacogenetic Variants and Level A Drugs Prescribed Among US Veterans Health Administration Pharmacy Users

IMPORTANCE: Implementation of pharmacogenetic testing to guide drug prescribing has potential to improve drug response and prevent adverse events. Robust data exist for more than 30 gene-drug pairs linking genotype to drug response phenotypes; however, it is unclear which pharmacogenetic tests, if i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chanfreau-Coffinier, Catherine, Hull, Leland E., Lynch, Julie A., DuVall, Scott L., Damrauer, Scott M., Cunningham, Francesca E., Voight, Benjamin F., Matheny, Michael E., Oslin, David W., Icardi, Michael S., Tuteja, Sony
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2019
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6563578/ https://www.ncbi.nlm.nih.gov/pubmed/31173123 http://dx.doi.org/10.1001/jamanetworkopen.2019.5345

Ejemplares similares

CYP2C19 Polymorphisms and Clinical Outcomes Following Percutaneous Coronary Intervention (PCI) in the Million Veterans Program
por: Chanfreau-Coffinier, Catherine, et al.
Publicado: (2023)

Primary care and mental health providers’ perceptions of implementation of pharmacogenetics testing for depression prescribing
por: Vest, Bonnie M., et al.
Publicado: (2020)

Clinical decisions surrounding genomic and proteomic testing among United States veterans treated for lung cancer within the Veterans Health Administration
por: Efimova, Olga, et al.
Publicado: (2017)

Demographic Differences Among US Department of Veterans Affairs Patients Referred for Genetic Consultation to a Centralized VA Telehealth Program, VA Medical Centers, or the Community
por: Scheuner, Maren T., et al.
Publicado: (2022)

Pharmacogenetic variants and risk of remdesivir‐associated liver enzyme elevations in Million Veteran Program participants hospitalized with COVID‐19
por: Tuteja, Sony, et al.
Publicado: (2022)

2292. Measuring Effectiveness against a Shifting Variant Landscape: COVID-19 Example in the Department of Veterans Affairs
por: DuVall, Scott L, et al.
Publicado: (2023)

Evaluating the frequency and the impact of pharmacogenetic alleles in an ancestrally diverse Biobank population
por: Verma, Shefali S., et al.
Publicado: (2022)

Identification of methicillin-resistant Staphylococcus aureus within the Nation’s Veterans Affairs Medical Centers using natural language processing
por: Jones, Makoto, et al.
Publicado: (2012)

Comparison of automated and retrospectively calculated estimated glomerular filtration rate in electronic health record data
por: Lynch, Kristine E., et al.
Publicado: (2018)

Implementing clinical decision support for reducing women Veterans' cardiovascular risk in VA: A mixed-method, longitudinal study of context, adaptation, and uptake
por: Brunner, Julian, et al.
Publicado: (2022)

High rates of early treatment discontinuation in hepatitis C-infected US veterans
por: LaFleur, Joanne, et al.
Publicado: (2014)

Association of Sex and Race With Incident Peripheral Artery Disease Among Veterans With Normal Ankle-Brachial Indices
por: Aday, Aaron W., et al.
Publicado: (2022)

Self-reported physical functioning, cardiometabolic health conditions, and health care utilization patterns in Million Veteran Program enrollees with Traumatic Brain Injury Screening and Evaluation Program data
por: Clark, Alexandra L., et al.
Publicado: (2023)

Evaluation of Suicide Mortality Among Sexual Minority US Veterans From 2000 to 2017
por: Lynch, Kristine E., et al.
Publicado: (2020)

Antidepressant prescribing in the precision medicine era: a prescriber’s primer on pharmacogenetic tools
por: Bousman, Chad A., et al.
Publicado: (2017)

Pharmacogenetic testing in the Veterans Health Administration: Policy recommendations from the VHA Clinical Pharmacogenetics Subcommittee
por: Vassy, Jason L., et al.
Publicado: (2018)

97856 Implementation of DPYD and UGT1A1 pharmacogenetic testing to guide chemotherapy dosing
por: Varughese, Lisa A., et al.
Publicado: (2021)

Pharmacogenetic actionability and medication prescribing in people with cystic fibrosis
por: Anderson, Justin D., et al.
Publicado: (2023)

Validating a non-invasive, ALT-based non-alcoholic fatty liver phenotype in the million veteran program
por: Serper, Marina, et al.
Publicado: (2020)

Preemptive pharmacogenetic testing to guide chemotherapy dosing in patients with gastrointestinal malignancies: a qualitative study of barriers to implementation
por: Lau-Min, Kelsey S., et al.
Publicado: (2022)

911. Burden of Herpes Zoster among Employed Adults in the Department of Veterans Affairs Health System
por: Gupta, Shaloo, et al.
Publicado: (2023)

Multisite evaluation of institutional processes and implementation determinants for pharmacogenetic testing to guide antidepressant therapy
por: Tuteja, Sony, et al.
Publicado: (2021)

Pharmacy Benefits Management in the Veterans Health Administration Revisited: A Decade of Advancements, 2004-2014
por: Aspinall, Sherrie L., et al.
Publicado: (2016)

Antibiotic Prescribing by Dentists and Geographic Variability in the Veterans Affairs (VA) Health System
por: Acosta, Kaitlyn, et al.
Publicado: (2017)

Exploring the affective toxicity of commonly prescribed medications in the elderly
por: Oslin, David W., et al.
Publicado: (1999)

Pharmacogenetic testing and counselling in the community pharmacy: mixed-methods study of a new pharmacist-led service
por: Jeiziner, Chiara, et al.
Publicado: (2023)

Investigation of factors influencing inpatient antibiotic prescribing decisions in the Veterans’ Health Administration
por: Economos, Evan T., et al.
Publicado: (2022)

Angina Severity, Mortality, and Healthcare Utilization Among Veterans With Stable Angina
por: Owlia, Mina, et al.
Publicado: (2019)

Feasibility of pharmacy-initiated pharmacogenetic screening for CYP2D6 and CYP2C19
por: Swen, J. J., et al.
Publicado: (2011)

Genome-wide Association Study of Peripheral Artery Disease in the Million Veteran Program
por: Klarin, Derek, et al.
Publicado: (2019)

Epidemiology of nontuberculous mycobacterial infections in the U.S. Veterans Health Administration
por: Jones, Makoto M., et al.
Publicado: (2018)

Pharmacogenetic-guided cannabis usage in the community pharmacy: evaluation of a pilot program
por: Papastergiou, John, et al.
Publicado: (2020)

Phenome-wide association of 1809 phenotypes and COVID-19 disease progression in the Veterans Health Administration Million Veteran Program
por: Song, Rebecca J., et al.
Publicado: (2021)

Inpatient, Outpatient, and Pharmacy Costs in Patients With and Without HIV in the US Veteran’s Affairs Administration System
por: Sutton, Scott, et al.
Publicado: (2019)

Women Veterans’ Healthcare Needs, Utilization, and Preferences in Veterans Affairs Primary Care Settings
por: Sheahan, Kate L., et al.
Publicado: (2022)

Assessment of Prescribing Practices and Factors Related to Antibiotic Prescribing in Community Pharmacies
por: Rabbani, Syed Arman, et al.
Publicado: (2023)

Best–worst scaling methodology to evaluate constructs of the Consolidated Framework for Implementation Research: application to the implementation of pharmacogenetic testing for antidepressant therapy
por: Salloum, Ramzi G., et al.
Publicado: (2022)

Designated prescribing practitioners: a theory-based cross-sectional study of stakeholders’ views on implementation of a novel pharmacy regulator mandated preceptorship model
por: Jebara, Tesnime, et al.
Publicado: (2022)

Mapping eGFR loci to the renal transcriptome and phenome in the VA Million Veteran Program
por: Hellwege, Jacklyn N., et al.
Publicado: (2019)

Pharmacy use by dual-eligible non-elderly veterans with private healthcare insurance
por: Lund, Brian C., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_l8lc2frurgogmrtefabs9l4hsk